I have morning coffee with a friend who is diabetic, one of two I know of, but my sister is also type 2. I forwarded him some links on information including afrezzaur's link and Adam Lasher's. He says he's going to speak with his doctor about it. That's how this will become a blockbuster in no time. Getting to market was key. Eventually the labels will allow them to tell the whole truth - fast acting, reduces hypos...the list goes on.
He thanked me sincerely for caring!
That's another reason why this is going to be a blockbuster. Wouldn't you like to be the one that changed someone's life for the better, maybe three to six months sooner than they may have otherwise heard about it?
From first day user Nicole Augenti, Esq. Type1 Day 1 on Afrezza.... And it's AWESOME. #afrezzalove.
Folks, AF can say want he wants, but social media will take Afrezza to the moon. It's happening. There is no stopping it. The Short posting on the board is already looking like twilight zone posts because you can see the reaction from true Diabetics on a life-changing drug. It is a slow-moving train to be exact and it will soon roll right over you if you are standing in it's way.
It's quite obvious you should sell and move on. I bought more on Friday, and I could care less what the stock does next week. Next week is not why I invested in MNKD, but at some un-anticipated moment you will wish that last week or yesterday you had been holding your shares.
Name any of those that required and endo visit and lung function test as prerequisite.
If the shorts were going to make the failure comparison before it hit the market let's not change the subject now, without first agreeing that 21x proves there IS NO COMPARISON, and Afrezza, in that comparison trumpeted by those in doubt, is quickly showing everyone THERE IS NO COMPARISON. Afrezza may well revolutionize treatment for a majority of diabetics. That much won't happen overnight, but by the time they obtain EU approval and start rolling out in other countries, there will likely be a paradigm shift underway in the treatment of diabetes taking hold in the U.S. By that time it will be well recognized as a blockbuster drug. This, not even considering the technosphere platform potential with other drugs.
That explains a lot, thanks for clarifying it was GP and not an endo. I have a mid-april appointment to see mine, and I will ask about it, even though I am not a diabetic...adult type 2 may be an issue for me at anytime in my life as it was as my parents aged.
Today the AF crowd and the soft-bashers had to lean only on bogus headlines about disappointing initial sales, but without any basis. Why is their no basis?
Because up to this point they were comparing it with Exubera, and 3 weeks in it's already obvious we are blowing exubera numbers out and today they had to distanced themselves completely from the comparison they were trumpeting earlier, because such a comparison is already saying that in three weeks Afreeza is hitting exubera six week numbers. It will get even more apparent in the weeks to come, and it will be well worth the wait.
My money says afrezzaur would rip you new one...Better hope he has a cartridge of smelling salts to pop into his inhaler and waive under your nose once it's all over with.
Love it...and other Company developments...boilerplate language....sure shorty...sure...that's the ticket
That's the way planned sales work, they were set months and months ago to occur and they happen irrespective of the shareprice. St. Management receives enough of these that they care not about trading the stock. The mistake would be to read too much into a planned stock sale.
They might just be waiting for a certain stock price to announce it for another huge leg up! LOL
SEC 13G Filing for BlackRock - check it out!!!! Going back up!!!
This finding will give Rudy Tanzi a wet dream...sorry for not having any class whatsoever and saying that...